✦ LIBER ✦

The role of autologous transplantation in patients with multiple myeloma aged 65 years and over

✍ Scribed by Sirohi, B; Powles, R; Treleaven, J; Mainwaring, P; Kulkarni, S; Pandha, H; Bhagwati, N; Horton, C; Singhal, S; Mehta, J

Book ID: 110012421
Publisher: Nature Publishing Group
Year: 2000
Tongue: English
Weight: 72 KB
Volume: 25
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1702188

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic factors in elderly multiple m

Prognostic factors in elderly multiple myeloma patients aged 65 years or older: Comparison with nonelderly patients with multiple myeloma

✍ Masanori Umeda; Shinya Okuda; Haruka Izumi; Yasuyuki Sugasawa; Chiaki Arai; Kazu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Autologous stem cell transplantation in

Autologous stem cell transplantation in multiple myeloma patients <60 vs 60 years of age

✍ Reece, D E; Bredeson, C; Pérez, W S; Jagannath, S; Zhang, M J; Ballen, K K; Elfe 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 165 KB

High-dose chemotherapy and autologous he

High-dose chemotherapy and autologous hematopoietic stem cell transplantation in myeloma patients under the age of 65 years

✍ Mehta, J; Singhal, S 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 258 KB

The impact of race on outcomes of autolo

The impact of race on outcomes of autologous transplantation in patients with multiple myeloma

✍ Pramvir S. Verma; Robin S. Howard; Brendan M. Weiss 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views

Limited feasibility of double transplant

Limited feasibility of double transplant in multiple myeloma : Results of a multicenter study on 153 patients aged <65 years

✍ Alessandro Corso; Silvia Mangiacavalli; Luciana Barbarano; Emilio Paolo Alessand 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB

## Abstract ## BACKGROUND. Although high‐dose therapy is considered the standard therapy for younger patients with multiple myeloma (MM), the advantages of performing a second transplant remain debated. The current study was conducted to evaluate the efficacy and the feasibility of a front‐line do

Autologous stem cell transplantation in

Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: Results from a matched pair analysis

✍ Shaji K. Kumar; David Dingli; Martha Q. Lacy; Angela Dispenzieri; Suzanne R. Hay 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

## Abstract High‐dose therapy and autologous stem cell transplant (HDT) have been shown to prolong survival in multiple myeloma (MM) in randomized trials, but only included patients of 65 years or younger. Given the median age at diagnosis of 66 years, it is important to have a better understanding